Key result
Cardiac MRI successfully identified one case of Arrhythmogenic Right Ventricular Dysplasia among 43 patients by detecting abnormal right ventricular volumes (RVEDVi 110 ml/m²), reduced ejection fraction (36%), and fibrotic areas.
Why the study?
Arrhythmogenic right ventricular dysplasia can lead to severe arrhythmias and sudden cardiac death, requiring evaluation of MRI for early diagnosis and morpho-functional monitoring.
Does Magnetic Resonance Imaging (MRI) allow for the accurate morpho-functional evaluation and diagnosis of Arrhythmogenic Right Ventricular dysplasia (ARVD)?
Observational (n=43)
No
Does Magnetic Resonance Imaging (MRI) allow for the accurate morpho-functional evaluation and diagnosis of Arrhythmogenic Right Ventricular dysplasia (ARVD)?
MRI is an effective diagnostic tool for identifying Arrhythmogenic Right Ventricular dysplasia (ARVD) by evaluating right ventricular morpho-functional parameters against established Task Force criteria.
MRI may aid ARVD evaluation in athletes; leaves open larger prospective validation before practice change.
Arrhythmogenic Right Ventricular dysplasia (ARVD) is an inherited disease characterized by fibro-adipose replacement of cardiac tissue, which can lead to severe arrhythmias and sudden cardiac death, especially in young athletes. This experimental study analyzes the efficacy of Magnetic Resonance Imaging (MRI) in the early diagnosis and monitoring of ARVD, highlighting how this diagnostic technique represents the gold standard for the morpho-functional evaluation of the right ventricle. 43 patients were examined, one of whom tested positive for ARVD, thanks to the diagnostic parameters obtained (RVEDVi, RVESVi and FE) and Delayed enhancement sequences by MRI. It was found that the reference parameters of the TASK FORCE 2010 were exceeded with values of RVEDVi equal to 110 ml/m² and FE equal to 36% and in the DE sequences we had an accumulation of contrast medium in the free wall of the right ventricle.
No takes yet. Share an insight, caveat, or question.
Dargenio et al. (2025) conducted an observational in Arrhythmogenic Right Ventricular Dysplasia (ARVD) (n=43). Cardiac Magnetic Resonance Imaging (MRI) vs. 2010 Task Force reference values was evaluated on Detection of Arrhythmogenic Right Ventricular Dysplasia (ARVD). Cardiac MRI successfully identified one case of Arrhythmogenic Right Ventricular Dysplasia among 43 patients by detecting abnormal right ventricular volumes (RVEDVi 110 ml/m²), reduced ejection fraction (36%), and fibrotic areas.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: